Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study

PURPOSE: To assess the efficacy of pembrolizumab in patients with advanced relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS). PATIENTS AND METHODS: CITN-10 is a single-arm, multicenter phase II trial of 24 patients with advanced MF or SS. Patients were treated with pembrolizumab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Khodadoust, Michael S., Rook, Alain H., Porcu, Pierluigi, Foss, Francine, Moskowitz, Alison J., Shustov, Andrei, Shanbhag, Satish, Sokol, Lubomir, Fling, Steven P., Ramchurren, Nirasha, Pierce, Robert, Davis, Asa, Shine, Richard, Li, Shufeng, Fong, Sophia, Kim, Jinah, Yang, Yi, Blumenschein, Wendy M., Yearley, Jennifer H., Das, Biswajit, Patidar, Rajesh, Datta, Vivekananda, Cantu, Erin, McCutcheon, Justine N., Karlovich, Chris, Williams, P. Mickey, Subrahmanyam, Priyanka B., Maecker, Holden T., Horwitz, Steven M., Sharon, Elad, Kohrt, Holbrook E., Cheever, Martin A., Kim, Youn H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6943974/
https://ncbi.nlm.nih.gov/pubmed/31532724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01056
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados